PCH
IMNM icon

Polar Capital Holdings’s Immunome IMNM Stock Holding History

Polar Capital Holdings’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.6M Buy
849,479
+56,115
+7% +$1.25M 0.07% 149
2025
Q4 		$17M Sell
793,364
-265,412
-25% -$4.66M 0.07% 164
2025
Q3 		$12.4M Buy
1,058,776
+58,776
+6% +$585K 0.06% 190
2025
Q2 		$9.3M Buy
+1,000,000
New +$8.2M 0.05% 200

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Polar Capital Holdings's IMNM Position: Q1 2026 in Review

Polar Capital Holdings increased its Immunome (IMNM) stake by 7.1% in Q1 2026, buying an estimated $1.25M and bringing the position to 849,479 shares worth $18.6M. The position accounts for 0.07% of the portfolio, ranked #149.

Polar Capital Holdings first reported a position in IMNM in Q2 2025 and has held it in 4 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Polar Capital Holdings held 849,479 shares of Immunome worth $18.6M as of Q1 2026.
  • Polar Capital Holdings bought 56,115 Immunome shares in Q1 2026, an estimated $1.25M.
  • Immunome made up 0.07% of Polar Capital Holdings's portfolio in Q1 2026, its #149 holding.
  • Polar Capital Holdings first reported a position in Immunome in Q2 2025 and has held it in 4 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Polar Capital Holdings's 13F filing for Q1 2026, filed 15 May 2026.